Justices Won't Hear Drugmakers' OxyContin Patent Appeal
By Suevon Lee ( November 14, 2016, 7:06 PM EST) -- Purdue Pharma LP and Grunenthal GmbH lost their bids to have the U.S. Supreme Court take up their challenge to a Federal Circuit's nix of asserted claims of four patents relating to painkiller OxyContin when the justices Monday denied certiorari....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.